Unknown

Dataset Information

0

Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.


ABSTRACT: It has long been speculated that psychedelic use could provoke the onset of psychosis, but there is little evidence to support this conjecture. Using a longitudinal research design with samples representative of the US and UK adult populations with regard to sex, age, and ethnicity (n = 9732), we investigated associations between psychedelic use and change in the number of psychotic symptoms during the two-month study period. In covariate-adjusted regression models, psychedelic use during the study period was not associated with a change in the number of psychotic symptoms unless it interacted with a personal or family history of bipolar disorder, in which case the number of symptoms increased, or with a personal (but not family) history of psychotic disorders, in which case the number of symptoms decreased. Taken together, these findings indicate that psychedelic use may affect psychotic symptoms in individuals with a personal or family history of certain disorders characterized by psychotic symptomatology.

SUBMITTER: Honk L 

PROVIDER: S-EPMC10922895 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.

Honk Ludwig L   Stenfors Cecilia U D CUD   Goldberg Simon B SB   Hendricks Peter S PS   Osika Walter W   Dourron Haley Maria HM   Lebedev Alexander A   Petrovic Predrag P   Simonsson Otto O  

Journal of affective disorders 20240126


It has long been speculated that psychedelic use could provoke the onset of psychosis, but there is little evidence to support this conjecture. Using a longitudinal research design with samples representative of the US and UK adult populations with regard to sex, age, and ethnicity (n = 9732), we investigated associations between psychedelic use and change in the number of psychotic symptoms during the two-month study period. In covariate-adjusted regression models, psychedelic use during the st  ...[more]

Similar Datasets

| S-EPMC4146535 | biostudies-literature
| S-EPMC8277805 | biostudies-literature
| S-EPMC11999004 | biostudies-literature
| S-EPMC10292839 | biostudies-literature